# PACS Group, Inc. (PACS) Stock Analysis: A 52.73% Potential Upside in Healthcare Facilities

- Link: https://www.directorstalkinterviews.com/pacs-group-inc-pacs-stock-analysis-a-52-73-potential-upside-in-healthcare-facilities/4121247389
- Published: 2026-03-31T10:26:43+01:00
- Author: Madison Wilson

PACS Group, Inc. (NASDAQ: PACS) is drawing significant investor attention with a
remarkable potential upside of 52.73%, according to analyst ratings. As a key player
in the healthcare sector, PACS operates skilled nursing facilities and assisted 
living spaces across the United States. The company has carved a niche in the medical
care facilities industry, focusing on the acquisition, ownership, and leasing of
healthcare properties. With a market capitalization of $4.77 billion, PACS is a 
substantial player in this critical sector.

Currently trading at $30.38, PACS has experienced a modest price change of -0.21(-
0.01%) amidst a 52-week range of $7.71 to $42.13. This vast range underscores the
volatility and growth potential of the stock. It is crucial for investors to note
that the Relative Strength Index (RSI) stands at 21.58, indicating that the stock
is oversold, potentially offering a buying opportunity for value-seeking investors.

PACS’s forward Price-to-Earnings (P/E) ratio of 12.87 suggests that the market is
moderately optimistic about the company’s future earnings growth. However, the absence
of trailing P/E and PEG ratios indicates that PACS is in a growth phase, focusing
on reinvestment into its operations and expansion strategies rather than generating
immediate profits.

The company’s revenue growth of 12.40% is a testament to its robust business model,
while a Return on Equity (ROE) of 22.96% highlights efficient management and strong
profit generation relative to shareholder equity. Additionally, PACS boasts a substantial
free cash flow of $241.9 million, which provides flexibility for further investments,
debt reduction, or potential shareholder returns in the future.

Despite its strong financial performance, PACS does not currently offer a dividend,
maintaining a payout ratio of 0.00%. This strategy aligns with its focus on reinvestment
to sustain growth and capitalize on emerging opportunities within the healthcare
sector.

Investor sentiment remains overwhelmingly positive, with five analysts rating the
stock as a “Buy” and no “Hold” or “Sell” ratings. The stock’s average target price
is set at $46.40, with a range between $42.00 and $52.00, suggesting substantial
room for appreciation. This bullish outlook is further supported by the stock’s 
performance metrics and the increasing demand for healthcare services.

Technically, PACS is trading below both its 50-day moving average of $36.08 and 
200-day moving average of $22.56, indicating potential resistance levels that could
be overcome with continued investor confidence and strong operational performance.
The Moving Average Convergence Divergence (MACD) indicator shows a signal line of-
1.07, suggesting the potential for a reversal in PACS’s recent price decline.

Founded in 2013 and headquartered in Salt Lake City, Utah, PACS Group, Inc. is strategically
positioned to benefit from the aging population and the growing need for healthcare
facilities. As it continues to expand its footprint and enhance its service offerings,
PACS presents a compelling investment opportunity for those looking to capitalize
on long-term growth in the healthcare sector.

Share on: